Paw, M.; Wnuk, D.; Nit, K.; Bobis-Wozowicz, S.; Szychowski, R.; Ślusarczyk, A.; Madeja, Z.; Michalik, M.
SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma. Int. J. Mol. Sci. 2021, 22, 12790.
https://doi.org/10.3390/ijms222312790
AMA Style
Paw M, Wnuk D, Nit K, Bobis-Wozowicz S, Szychowski R, Ślusarczyk A, Madeja Z, Michalik M.
SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma. International Journal of Molecular Sciences. 2021; 22(23):12790.
https://doi.org/10.3390/ijms222312790
Chicago/Turabian Style
Paw, Milena, Dawid Wnuk, Kinga Nit, Sylwia Bobis-Wozowicz, Rafał Szychowski, Alicja Ślusarczyk, Zbigniew Madeja, and Marta Michalik.
2021. "SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma" International Journal of Molecular Sciences 22, no. 23: 12790.
https://doi.org/10.3390/ijms222312790
APA Style
Paw, M., Wnuk, D., Nit, K., Bobis-Wozowicz, S., Szychowski, R., Ślusarczyk, A., Madeja, Z., & Michalik, M.
(2021). SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma. International Journal of Molecular Sciences, 22(23), 12790.
https://doi.org/10.3390/ijms222312790
